• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症状态和身体成分预测局部晚期头颈部鳞状细胞癌患者在同步放化疗期间给予推荐能量摄入时的两年死亡率。

Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy.

作者信息

Lin Yu-Ching, Wang Cheng-Hsu, Ling Hang Huong, Pan Yi-Ping, Chang Pei-Hung, Chou Wen-Chi, Chen Fang-Ping, Yeh Kun-Yun

机构信息

Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital, College of Medicine, Keelung & Chang Gung University, Taoyuan 333007, Taiwan.

Osteoporosis Prevention and Treatment Center, Chang Gung Memorial Hospital, Keelung 20401, Taiwan.

出版信息

Biomedicines. 2022 Feb 6;10(2):388. doi: 10.3390/biomedicines10020388.

DOI:10.3390/biomedicines10020388
PMID:35203597
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8962429/
Abstract

Only few prospective cohort trials have evaluated the risk factors for the 2-year mortality rate between two patient subgroups with locally advanced head and neck squamous cell carcinoma (LAHNSCC): oral cavity cancer with adjuvant concurrent chemoradiotherapy (CCRT) (OCC) and non-oral cavity cancer with primary CCRT (NOCC), under the recommended calorie intake and investigated the interplay among calorie supply, nutrition-inflammation biomarkers (NIBs), and total body composition change (TBC), as assessed using dual-energy X-ray absorptiometry (DXA). Patients with LAHNSCC who consumed at least 25 kcal/kg/day during CCRT were prospectively recruited. Clinicopathological variables, blood NIBs, CCRT-related factors, and TBC data before and after treatment were collected. Factor analysis was performed to reduce the number of anthropometric and DXA-derived measurements. Cox proportional hazards models were used for analysis. We enrolled 123 patients with LAHNSCC (69 with OCC and 54 with NOCC). The mean daily calorie intake correlated with the treatment interval changes in total body muscle and fat. Patients consuming ≥30 kcal/kg/day had lower pretreatment levels but exhibited fewer treatment interval changes in anthropometric and DXA measurements than patients consuming <30 kcal/kg/day. In the multivariate analysis of the 2-year mortality rate, the prognostic influence of the recommended calorie intake could not be confirmed, but different risk factors (performance status, pretreatment platelet-to-lymphocyte ratio, and treatment interval body muscle changes in patients with OCC; age, pretreatment neutrophil-to-lymphocyte ratio, and body fat storage in patients with NOCC) showed independent effects. Therefore, the inflammation status and body composition, but not the recommended calorie supply, contribute to the 2-year mortality rate for patients with LAHNSCC receiving CCRT.

摘要

仅有少数前瞻性队列试验评估了局部晚期头颈部鳞状细胞癌(LAHNSCC)两个患者亚组之间2年死亡率的风险因素:接受辅助同步放化疗(CCRT)的口腔癌(OCC)和接受原发CCRT的非口腔癌(NOCC),这些试验是在推荐热量摄入情况下进行的,并研究了热量供应、营养炎症生物标志物(NIBs)和使用双能X线吸收法(DXA)评估的全身成分变化(TBC)之间的相互作用。前瞻性招募了在CCRT期间每日至少摄入25千卡/千克的LAHNSCC患者。收集临床病理变量、血液NIBs、CCRT相关因素以及治疗前后的TBC数据。进行因子分析以减少人体测量和DXA衍生测量的数量。使用Cox比例风险模型进行分析。我们纳入了123例LAHNSCC患者(69例OCC患者和54例NOCC患者)。每日平均热量摄入与全身肌肉和脂肪的治疗间隔变化相关。摄入≥30千卡/千克/天的患者预处理水平较低,但与摄入<30千卡/千克/天的患者相比,其人体测量和DXA测量的治疗间隔变化较少。在对2年死亡率的多变量分析中,无法确认推荐热量摄入的预后影响,但不同的风险因素(OCC患者的体能状态、预处理血小板与淋巴细胞比值以及治疗间隔期身体肌肉变化;NOCC患者的年龄、预处理中性粒细胞与淋巴细胞比值以及身体脂肪储存)显示出独立作用。因此,炎症状态和身体成分而非推荐的热量供应,对接受CCRT的LAHNSCC患者的2年死亡率有影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e63/8962429/1b3824fbedc9/biomedicines-10-00388-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e63/8962429/4483a1a7b455/biomedicines-10-00388-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e63/8962429/532ee202e4db/biomedicines-10-00388-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e63/8962429/1b3824fbedc9/biomedicines-10-00388-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e63/8962429/4483a1a7b455/biomedicines-10-00388-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e63/8962429/532ee202e4db/biomedicines-10-00388-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e63/8962429/1b3824fbedc9/biomedicines-10-00388-g003.jpg

相似文献

1
Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy.炎症状态和身体成分预测局部晚期头颈部鳞状细胞癌患者在同步放化疗期间给予推荐能量摄入时的两年死亡率。
Biomedicines. 2022 Feb 6;10(2):388. doi: 10.3390/biomedicines10020388.
2
Concurrent Chemoradiotherapy Induces Body Composition Changes in Locally Advanced Head and Neck Squamous Cell Carcinoma: Comparison between Oral Cavity and Non-Oral Cavity Cancer.同期放化疗诱导局部晚期头颈部鳞状细胞癌患者的体成分变化:口腔癌与非口腔癌的比较。
Nutrients. 2021 Aug 26;13(9):2969. doi: 10.3390/nu13092969.
3
Treatment-Interval Changes in Serum Levels of Albumin and Histidine Correlated with Treatment Interruption in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Completing Chemoradiotherapy under Recommended Calorie and Protein Provision.在推荐热量和蛋白质供应下完成放化疗的局部晚期头颈部鳞状细胞癌患者中,血清白蛋白和组氨酸水平的治疗间期变化与治疗中断相关。
Cancers (Basel). 2022 Jun 24;14(13):3112. doi: 10.3390/cancers14133112.
4
Comorbidity, Radiation Duration, and Pretreatment Body Muscle Mass Predict Early Treatment Failure in Taiwanese Patients with Locally Advanced Oral Cavity Squamous Cell Carcinoma after Completion of Adjuvant Concurrent Chemoradiotherapy.合并症、放疗疗程及治疗前身体肌肉质量可预测台湾局部晚期口腔鳞状细胞癌患者辅助同步放化疗结束后的早期治疗失败情况。
Diagnostics (Basel). 2021 Jul 2;11(7):1203. doi: 10.3390/diagnostics11071203.
5
Pretreatment predictive factors for feasibility of oral intake in adjuvant concurrent chemoradiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck.辅助同步放化疗治疗局部晚期头颈部鳞状细胞癌患者口服摄入可行性的预处理预测因素。
Int J Clin Oncol. 2020 Feb;25(2):258-266. doi: 10.1007/s10147-019-01560-5. Epub 2019 Oct 16.
6
Pretreatment Glasgow Prognostic Score Correlated with Serum Histidine Level and Three-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma and Optimal Performance Status.治疗前格拉斯哥预后评分与血清组氨酸水平及最佳体能状态局部晚期头颈部鳞状细胞癌患者 3 年死亡率的相关性。
Nutrients. 2022 Aug 24;14(17):3475. doi: 10.3390/nu14173475.
7
Characterization of changes in total body composition for patients with head and neck cancer undergoing chemoradiotherapy using dual-energy x-ray absorptiometry.使用双能X线吸收测定法对接受放化疗的头颈癌患者全身成分变化的特征分析
Head Neck. 2014 Sep;36(9):1356-62. doi: 10.1002/hed.23461. Epub 2013 Nov 21.
8
Early Loss of Fat Mass During Chemoradiotherapy Predicts Overall Survival in Locally Advanced Squamous Cell Carcinoma of the Lung, but Not in Locally Advanced Squamous Cell Carcinoma of the Head and Neck.放化疗期间早期脂肪量减少可预测局部晚期肺鳞癌的总生存期,但对局部晚期头颈部鳞癌则不然。
Front Nutr. 2020 Nov 26;7:600612. doi: 10.3389/fnut.2020.600612. eCollection 2020.
9
Assessment of Predictive Scoring System for 90-Day Mortality Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Completed Concurrent Chemoradiotherapy.局部晚期头颈部鳞状细胞癌患者同步放化疗后 90 天死亡率预测评分系统评估。
JAMA Netw Open. 2020 Mar 2;3(3):e1920671. doi: 10.1001/jamanetworkopen.2019.20671.
10
Role of the Appendicular Skeletal Muscle Index for Predicting the Recurrence-Free Survival of Head and Neck Cancer.上肢骨骼肌指数在预测头颈癌无复发生存率中的作用
Diagnostics (Basel). 2021 Feb 14;11(2):309. doi: 10.3390/diagnostics11020309.

引用本文的文献

1
The comparison of the prognostic value of different inflammation-related indicators in patients with oral squamous cell carcinoma.口腔鳞状细胞癌患者不同炎症相关指标的预后价值比较。
Front Genet. 2025 Aug 18;16:1652603. doi: 10.3389/fgene.2025.1652603. eCollection 2025.
2
A novel equation synthesis for estimating resting energy expenditure in prostate cancer patients.一种用于估计前列腺癌患者静息能量消耗的新型方程合成法。
BMC Urol. 2025 Mar 27;25(1):61. doi: 10.1186/s12894-024-01648-9.
3
Improving the nutritional evaluation in head neck cancer patients using bioelectrical impedance analysis: Not only the phase angle matters.

本文引用的文献

1
Concurrent Chemoradiotherapy Induces Body Composition Changes in Locally Advanced Head and Neck Squamous Cell Carcinoma: Comparison between Oral Cavity and Non-Oral Cavity Cancer.同期放化疗诱导局部晚期头颈部鳞状细胞癌患者的体成分变化:口腔癌与非口腔癌的比较。
Nutrients. 2021 Aug 26;13(9):2969. doi: 10.3390/nu13092969.
2
ESPEN practical guideline: Clinical Nutrition in cancer.ESPEN 实践指南:癌症患者的临床营养。
Clin Nutr. 2021 May;40(5):2898-2913. doi: 10.1016/j.clnu.2021.02.005. Epub 2021 Mar 15.
3
Prognostic Nutritional Index Predicts Toxicity in Head and Neck Cancer Patients Treated with Definitive Radiotherapy in Association with Chemotherapy.
使用生物电阻抗分析改善头颈癌患者的营养评估:不仅相位角重要。
J Cachexia Sarcopenia Muscle. 2024 Dec;15(6):2426-2436. doi: 10.1002/jcsm.13577. Epub 2024 Oct 24.
4
Body composition parameters were associated with response to abiraterone acetate and prognosis in patients with metastatic castration-resistant prostate cancer.体成分参数与转移性去势抵抗性前列腺癌患者对醋酸阿比特龙的反应和预后相关。
Cancer Med. 2023 Apr;12(7):8251-8266. doi: 10.1002/cam4.5640. Epub 2023 Feb 7.
5
Pretreatment Glasgow Prognostic Score Correlated with Serum Histidine Level and Three-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma and Optimal Performance Status.治疗前格拉斯哥预后评分与血清组氨酸水平及最佳体能状态局部晚期头颈部鳞状细胞癌患者 3 年死亡率的相关性。
Nutrients. 2022 Aug 24;14(17):3475. doi: 10.3390/nu14173475.
6
Treatment-Interval Changes in Serum Levels of Albumin and Histidine Correlated with Treatment Interruption in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Completing Chemoradiotherapy under Recommended Calorie and Protein Provision.在推荐热量和蛋白质供应下完成放化疗的局部晚期头颈部鳞状细胞癌患者中,血清白蛋白和组氨酸水平的治疗间期变化与治疗中断相关。
Cancers (Basel). 2022 Jun 24;14(13):3112. doi: 10.3390/cancers14133112.
预后营养指数预测联合化疗行根治性放疗的头颈部癌症患者的毒性。
Nutrients. 2021 Apr 13;13(4):1277. doi: 10.3390/nu13041277.
4
Role of the Appendicular Skeletal Muscle Index for Predicting the Recurrence-Free Survival of Head and Neck Cancer.上肢骨骼肌指数在预测头颈癌无复发生存率中的作用
Diagnostics (Basel). 2021 Feb 14;11(2):309. doi: 10.3390/diagnostics11020309.
5
Nutritional Deficiencies in Radiotherapy-Treated Head and Neck Cancer Patients.接受放射治疗的头颈癌患者的营养缺乏情况
J Clin Med. 2021 Feb 3;10(4):574. doi: 10.3390/jcm10040574.
6
Mass spectrometry-based lipidomics of oral squamous cell carcinoma tissue reveals aberrant cholesterol and glycerophospholipid metabolism - A Pilot study.基于质谱的口腔鳞状细胞癌组织脂质组学揭示胆固醇和甘油磷脂代谢异常——一项初步研究。
Transl Oncol. 2020 Oct;13(10):100807. doi: 10.1016/j.tranon.2020.100807. Epub 2020 Jun 16.
7
Nutritional Issues in Head and Neck Cancer Patients.头颈癌患者的营养问题
Healthcare (Basel). 2020 Apr 17;8(2):102. doi: 10.3390/healthcare8020102.
8
Determining Malnutrition Assessment Criteria to Predict One-Year Mortality for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy.确定营养不良评估标准以预测同期放化疗的局部晚期头颈部癌症患者一年死亡率。
Nutrients. 2020 Mar 20;12(3):836. doi: 10.3390/nu12030836.
9
Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies.顺铂诱导的骨骼肌功能障碍:机制与治疗策略的对抗。
Int J Mol Sci. 2020 Feb 13;21(4):1242. doi: 10.3390/ijms21041242.
10
Chemotherapy-Induced Sarcopenia.化疗相关性肌肉减少症。
Curr Treat Options Oncol. 2020 Jan 30;21(1):7. doi: 10.1007/s11864-019-0691-9.